Choice Equity Broking is bullish on Senores Pharma has recommended buy rating on the stock with a target price of Rs 1010 in its research report dated November 07, 2025.

This paper introduces a novel AI-enhanced retirement planning platform that integrates behavioral economics principles with advanced machine learning techniques to optimize financial decision-making.

Tools like PROMPTFLUX “dynamically generate malicious scripts, obfuscate their own code to evade detection, and leverage AI ...